4Kremery VJr,Matejicka F,Pichnova E,et al.Documented fungal infection after prophylaxis or therapy with wide spectrum antibiotics:relationship between certain fungal pathogens and particular antimicrobials[J].J Chemother,1999,(5):385-390.
5Richardson MD,Kokki MH.New perspectives in the diagnosis of systemic fungal infections[J].Ann Med,1999,31(5):327-335.
6Jantunen E,Ruutu P,Niskanen L,et al.Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients[J].Bone Marrow Transplant,1997,19(8):801-808.
7Donnell MR,Schmidt GM,Tegtmeier BR,et al.Prediction of systemic fungal infection in allogeneic marrow recipients:impact of amphotericin prophylaxis in high risk patients[J].J Clin Oncol,1994,12(4):827-834.
8Cornely OA,Ullmann AJ,Karthaus M.Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies[J].Blood,2003,101 (9):3365-3372.
9Chryssanthou E,Klingsport L,Tollemar J,et al.PCR and other non-culture methods for diagnosis of invasive Candida infections in allogeneic bone marrow and solid organ transplant recipients[J].Mycoses,1999,42(4):239-247.
10Houang ET,Chu KC,Koeher AP,et al.Use of CHROMagar Candida for genital specimens in the diagnostic laboratory[J].J Clin Pathol,1997,50(7):563.
